We support our Publishers and Content Creators. You can view this story on their website by CLICKING HERE.

Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe for the use of its jab for adolescents.

The European Commission extended the current marketing authorization for Bavarian’s inoculation to include adolescents 12 to 17 years of age, the company said on Thursday. To date, the shot has only been indicated for adults.